Obligacje ABBVD
Poniżej znajduje się lista obligacji korporacyjnych AbbVie, Inc. Shs Cert Deposito Arg Repr 0.1. Inwestorzy często wybierają obligacje spółek ze względu na ich zwiększoną stabilność w czasach zmienności rynkowej. Przeanalizuj ceny, rentowności i inne statystyki, aby znaleźć wiarygodną inwestycję.
Symbol | YTM % | Wolumen | Cena % | Kupon % | Termin zapadalności | Kwota niezapłacona | Wartość nominalna | Min. kw. nominału | Emitent |
---|---|---|---|---|---|---|---|---|---|
AACT4218883Allergan Funding SCS 4.75% 15-MAR-2045 | 7,00% | 26 K | 76,04% | 4,75% | 2045-03-15 | 53,51 M USD | 1 000,00 USD | 2 000,00 USD | Allergan Funding SCS |
AACT3910526Actavis, Inc. 4.625% 01-OCT-2042 | 6,83% | 12 K | 77,91% | 4,63% | 2042-10-01 | 67,49 M USD | 1 000,00 USD | 2 000,00 USD | Actavis, Inc. |
AACT4176286Allergan Funding SCS 4.85% 15-JUN-2044 | 6,69% | 606 K | 80,50% | 4,85% | 2044-06-15 | 65,23 M USD | 1 000,00 USD | 2 000,00 USD | Allergan Funding SCS |
AACT4218882Allergan Funding SCS 4.55% 15-MAR-2035 | 5,88% | 621 K | 90,40% | 4,55% | 2035-03-15 | 107,65 M USD | 1 000,00 USD | 2 000,00 USD | Allergan Funding SCS |
5,57% | 0 | 91,64% | 2,63% | 2028-11-15 | 72,11 M EUR | 1 000,00 EUR | 100 000,00 EUR | Allergan Funding SCS | |
5,51% | 233 K | 99,77% | 5,50% | 2064-03-15 | 1,5 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
5,49% | 26 K | 90,47% | 3,20% | 2029-11-21 | 62,52 M USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
5,43% | 5,35 M | 102,46% | 5,60% | 2055-03-15 | 750 M USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
5,42% | 11,22 M | 99,62% | 5,40% | 2054-03-15 | 3 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
5,41% | 5,79 M | 84,32% | 4,25% | 2049-11-21 | 5,75 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
5,40% | 0 | 91,55% | 4,70% | 2045-05-14 | 2,7 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
5,39% | 0 | 88,30% | 4,45% | 2046-05-14 | 2 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
5,38% | 234 K | 93,24% | 4,88% | 2048-11-14 | 1,75 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
5,32% | 90 K | 93,09% | 4,75% | 2045-03-15 | 827,09 M USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
5,30% | 5 M | 94,68% | 4,85% | 2044-06-15 | 1,01 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
5,29% | 811 K | 100,63% | 5,35% | 2044-03-15 | 750 M USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
5,23% | 1,38 M | 90,57% | 4,40% | 2042-11-06 | 2,6 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
5,23% | 600 K | 93,20% | 4,63% | 2042-10-01 | 389,22 M USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
5,05% | 3,23 M | 89,93% | 4,05% | 2039-11-21 | 4 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
4,78% | 0 | 95,94% | 4,30% | 2036-05-14 | 1 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
4,72% | 0 | 98,26% | 4,50% | 2035-05-14 | 2,5 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
4,69% | 257 K | 98,93% | 4,55% | 2035-03-15 | 1,68 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
4,60% | 332 K | 104,52% | 5,20% | 2035-03-15 | 1 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
4,58% | 3,01 M | 103,24% | 5,05% | 2034-03-15 | 3 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
XXS162262122Allergan Funding SCS 2.125% 01-JUN-2029 | 4,28% | 0 | 92,75% | 2,13% | 2029-06-01 | 36,46 M EUR | 1 000,00 EUR | 100 000,00 EUR | Allergan Funding SCS |
4,17% | 15,78 M | 103,77% | 4,95% | 2031-03-15 | 2 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
4,08% | 0 | 99,43% | 3,20% | 2026-05-14 | 2 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
4,06% | 741 K | 103,32% | 4,88% | 2030-03-15 | 1 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
4,04% | 2,13 M | 96,78% | 3,20% | 2029-11-21 | 5,44 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
4,00% | 8,19 M | 102,59% | 4,80% | 2029-03-15 | 2,5 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
3,92% | 1,72 M | 101,26% | 4,80% | 2027-03-15 | 2,25 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
3,89% | 1,3 M | 98,89% | 2,95% | 2026-11-21 | 3,99 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
3,87% | 4,74 M | 101,82% | 4,65% | 2028-03-15 | 1,25 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
3,85% | 2,13 M | 101,13% | 4,25% | 2028-11-14 | 1,75 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
3,16% | 0 | 126,76% | 4,75% | 2045-03-15 | 5 K USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
3,13% | 0 | 128,71% | 4,85% | 2044-06-15 | 100 K USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
3,12% | 0 | 121,31% | 4,25% | 2049-11-21 | 4,95 M USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
2,99% | 0 | 90,34% | 1,25% | 2031-11-18 | 650 M EUR | 1 000,00 EUR | 100 000,00 EUR | AbbVie, Inc. | |
2,75% | 0 | 97,82% | 2,13% | 2029-06-01 | 506,09 M EUR | 1 000,00 EUR | 100 000,00 EUR | AbbVie, Inc. | |
2,57% | 0 | 123,74% | 4,55% | 2035-03-15 | 1 K USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
2,57% | 0 | 100,16% | 2,63% | 2028-11-15 | 427,79 M EUR | 1 000,00 EUR | 100 000,00 EUR | AbbVie, Inc. | |
2,50% | 0 | 98,85% | 2,13% | 2028-11-17 | 750 M EUR | 1 000,00 EUR | 100 000,00 EUR | AbbVie, Inc. | |
2,30% | 0 | 96,75% | 0,75% | 2027-11-18 | 750 M EUR | 1 000,00 EUR | 100 000,00 EUR | AbbVie, Inc. | |
−5,89% | 0 | 111,17% | 2,95% | 2026-11-21 | 9,24 M USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
— | — | — | 4,40% | 2042-11-06 | 1,1 M USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. |